Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study
Abstract The effect of blood pressure (BP) on the incident cardiovascular events, progression to end-stage renal disease (ESRD) and mortality were evaluated among chronic kidney disease (CKD) patients with and without antihypertensive treatment. This nationwide study used the Korean National Health...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f5711952a1c54440aa84da1849a19023 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f5711952a1c54440aa84da1849a19023 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f5711952a1c54440aa84da1849a190232021-12-02T15:22:57ZOptimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study10.1038/s41598-021-81328-y2045-2322https://doaj.org/article/f5711952a1c54440aa84da1849a190232021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-81328-yhttps://doaj.org/toc/2045-2322Abstract The effect of blood pressure (BP) on the incident cardiovascular events, progression to end-stage renal disease (ESRD) and mortality were evaluated among chronic kidney disease (CKD) patients with and without antihypertensive treatment. This nationwide study used the Korean National Health Insurance Service-Health Screening Cohort data. The hazards of outcomes were analysed according to the systolic BP (SBP) or diastolic BP (DBP) among adults (aged ≥ 40 years) with CKD and without previous cardiovascular disease or ESRD (n = 22,278). The SBP and DBP were ≥ 130 mmHg and ≥ 80 mmHg in 10,809 (48.52%) and 11,583 (51.99%) participants, respectively. During a median 6.2 years, 1271 cardiovascular events, 201 ESRD incidents, and 1061 deaths were noted. Individuals with SBP ≥ 130 mmHg and DBP ≥ 80 mmHg had higher hazards of hypertension-related adverse outcomes compared to the references (SBP 120–129 mmHg and DBP 70–79 mmHg). SBP < 100 mmHg was associated with hazards of all-cause death, and composite of ESRD and all-cause death during follow-up only among the antihypertensive medication users suggesting that the BP should be < 130/80 mmHg and the SBP should not be < 100 mmHg with antihypertensive agents to prevent the adverse outcome risk of insufficient and excessive antihypertensive treatment in CKD patients.You-Bin LeeJi Sung LeeSo-hyeon HongJung A. KimEun RohHye Jin YooSei Hyun BaikKyung Mook ChoiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q You-Bin Lee Ji Sung Lee So-hyeon Hong Jung A. Kim Eun Roh Hye Jin Yoo Sei Hyun Baik Kyung Mook Choi Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study |
description |
Abstract The effect of blood pressure (BP) on the incident cardiovascular events, progression to end-stage renal disease (ESRD) and mortality were evaluated among chronic kidney disease (CKD) patients with and without antihypertensive treatment. This nationwide study used the Korean National Health Insurance Service-Health Screening Cohort data. The hazards of outcomes were analysed according to the systolic BP (SBP) or diastolic BP (DBP) among adults (aged ≥ 40 years) with CKD and without previous cardiovascular disease or ESRD (n = 22,278). The SBP and DBP were ≥ 130 mmHg and ≥ 80 mmHg in 10,809 (48.52%) and 11,583 (51.99%) participants, respectively. During a median 6.2 years, 1271 cardiovascular events, 201 ESRD incidents, and 1061 deaths were noted. Individuals with SBP ≥ 130 mmHg and DBP ≥ 80 mmHg had higher hazards of hypertension-related adverse outcomes compared to the references (SBP 120–129 mmHg and DBP 70–79 mmHg). SBP < 100 mmHg was associated with hazards of all-cause death, and composite of ESRD and all-cause death during follow-up only among the antihypertensive medication users suggesting that the BP should be < 130/80 mmHg and the SBP should not be < 100 mmHg with antihypertensive agents to prevent the adverse outcome risk of insufficient and excessive antihypertensive treatment in CKD patients. |
format |
article |
author |
You-Bin Lee Ji Sung Lee So-hyeon Hong Jung A. Kim Eun Roh Hye Jin Yoo Sei Hyun Baik Kyung Mook Choi |
author_facet |
You-Bin Lee Ji Sung Lee So-hyeon Hong Jung A. Kim Eun Roh Hye Jin Yoo Sei Hyun Baik Kyung Mook Choi |
author_sort |
You-Bin Lee |
title |
Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study |
title_short |
Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study |
title_full |
Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study |
title_fullStr |
Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study |
title_full_unstemmed |
Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study |
title_sort |
optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/f5711952a1c54440aa84da1849a19023 |
work_keys_str_mv |
AT youbinlee optimalbloodpressureforpatientswithchronickidneydiseaseanationwidepopulationbasedcohortstudy AT jisunglee optimalbloodpressureforpatientswithchronickidneydiseaseanationwidepopulationbasedcohortstudy AT sohyeonhong optimalbloodpressureforpatientswithchronickidneydiseaseanationwidepopulationbasedcohortstudy AT jungakim optimalbloodpressureforpatientswithchronickidneydiseaseanationwidepopulationbasedcohortstudy AT eunroh optimalbloodpressureforpatientswithchronickidneydiseaseanationwidepopulationbasedcohortstudy AT hyejinyoo optimalbloodpressureforpatientswithchronickidneydiseaseanationwidepopulationbasedcohortstudy AT seihyunbaik optimalbloodpressureforpatientswithchronickidneydiseaseanationwidepopulationbasedcohortstudy AT kyungmookchoi optimalbloodpressureforpatientswithchronickidneydiseaseanationwidepopulationbasedcohortstudy |
_version_ |
1718387406576549888 |